StockData
Black Diamond Therapeutics, Inc. logo

Black Diamond Therapeutics, Inc. (BDTX) stock

BDTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$1.44−0.09 (-5.88%)

Close on Nov 17, 2026Market cap $82.73MP/E –Yield –

Black Diamond Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Black Diamond Therapeutics

Black Diamond Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Black Diamond Therapeutics figures

See a number that looks wrong?